West Pharmaceutical Services Inc

Healthcare · Medical Instruments & Supplies

371.10$ +2.6% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

West Pharmaceutical Services Inc (WST) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 3,074 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement WST
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	459	453	450	469	430	397	420	491	542	700	913	1,020	1,051	1,056	1,105	1,193	1,266	1,368	1,421	1,400	1,509	1,599	1,718	1,844	2,147	2,831	2,886	2,951	2,893	3,074
Cost of Revenue	302	289	282	289	290	281	302	335	374	506	652	728	749	752	787	854	879	934	974	944	1,008	1,087	1,172	1,235	1,379	1,657	1,747	1,818	1,891	1,970
Gross Profit	157	164	168	180	140	116	118	156	168	194	262	292	303	304	318	339	388	435	448	456	501	513	546	609	768	1,173	1,139	1,133	1,002	1,103
Research & Development	–	–	–	–	19	18	22	19	6.3	7.9	11	16	19	20	24	29	33	38	37	34	37	39	40	39	47	53	59	68	69	74
Selling, General & Administrative	73	70	71	78	68	73	83	111	105	120	156	153	159	178	188	191	218	235	229	233	240	243	263	273	302	363	344	353	339	389
Total Operating Expenses	104	102	103	114	105	75	81	81	104	121	156	179	178	198	212	223	251	273	266	267	277	282	292	312	349	415	375	422	408	486
Operating Income	53	62	65	66	36	41	27	55	64	73	106	113	125	106	106	116	137	162	182	129	197	229	255	297	419	759	764	711	595	617
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	14	13	15	16	15	14	15	15	15	13	13	7.0	6.5	8.1	8.0	8.5	8.5	7.6	8.8	2.9	0.6
Pre-Tax Income	27	58	28	57	3.1	28	17	47	41	64	86	89	110	86	79	99	113	147	169	116	190	222	248	301	419	769	701	716	600	615
Income Tax Expense	11	13	21	18	1.5	8.6	4.1	17	11	-0.4	25	17	24	14	14	24	33	40	47	26	54	81	41	59	73	107	115	122	108	122
Net Income	16	44	6.7	39	1.6	-5.2	18	32	19	46	67	71	86	73	65	76	81	112	127	96	144	151	207	242	346	662	586	593	493	494
EBITDA	84	94	97	102	76	75	83	85	95	123	150	158	186	166	161	183	200	248	272	219	288	326	353	403	519	880	808	844	744	724

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings